Slide Phakamisa_OurNews



Phuk_Article_thumb 1

AstraZeneca Country President Barbara Nel talks to Classic 1027 on AstraZeneca’s Phakamisa Patient-Public-Private Partnering

17 November 2020

Barbara Nel, Country President for African Cluster (South Africa, Sub Sahara and French Speaking Africa) for AstraZeneca spoke to Michael Avery from Classic 1027 on why AstraZeneca is expanding the Phakamisa initiative. This year Phakamisa is increasing its reach through partnerships with multiple healthcare stakeholders to improve breast and prostate cancer management in the public sector and specifically support patients in the early detection of disease, through our three-pillared approach of training, awareness and access.


To view the full podcast: Click here
Phuk_Article_thumb 5

On the Path to A South African Cancer Care Solution

October 2020

Dr Thulo Molefi, Specialist and Senior Lecturer, Department of Medical Oncology, Steve Biko Academic Hospital, University of Pretoria (South Africa) writes on the progress made to date in access to healthcare in South Africa and the work still to be done.


In a journey of a million miles, AstraZeneca’s Phakamisa initiative, in trying to increase cancer awareness, facilitate early diagnosis and fast-track pathways to treatment, is a step in the right direction.


To view the full article: Click here


Dr Molefi also spoke to Refiloe Mpakanyane on Radio 702 on the health burden of breast cancer in South Africa and his involvement in the Phakamisa programme

Phuk_Article_thumb 2

AstraZeneca’s Phakamisa programme marks 10 years since launch with programme expansion

27 November 2020

Partnering is key.


On 27 November at Steve Biko Academic Hospital (Tshwane District Hospital), representatives from across the health system jointly pledged to work together to improve health outcomes for patients in South Africa through AstraZeneca’s Phakamisa initiative. As community, civil society, government and private entity partners we are committed to bringing forth profound changes in healthcare by empowering patients, community healthcare outreach workers, and healthcare professionals.


To view the full press release: Click here

AstraZeneca’s Phakamisa supports Orange Farm Community Centre

September 2020

AstraZeneca’s Phakamisa programme, represented by Ruth Field, Market Access Director for AstraZeneca South Africa, visited Orange Farm Community Centre today to support Bishop Thabile Mnisi Msibi of the Mission Care Society and the district community health workers. The initiative focused on creating awareness and educating families and communities on the importance of cancer screening.

Phuk_Article_thumb 3

AstraZeneca’s Phakamisa Programme on the Dr Fundi digital health channel

12 December 2020

The Dr Fundi digital health channel hosted a virtual roundtable discussion on cancer screening, diagnosis and care. Joining Dr Nyati at the roundtable were Ruth Field, AstraZeneca’s Market Access Director in South Africa and Phakamisa lead, Salome Meyer, an independent cancer advocate from Cancer Alliance umbrella body of NPOs, and Dr Thulo Molefi, a Specialist Medical Oncologist from Steve Biko Academic Hospital.


To view the full roundtable discussion: Click here


Phakamisa has partnered with Proactive Health Solutions (PHS) Africa to provide integrated health and wellness solutions. Live coverage will be available on and

Phuk_Article_thumb 4

Phakamisa screening day at Steve Biko Academic Hospital

27 November 2020

AstraZeneca’s Phakamisa initiative held a Breast and Prostate Cancer screening day on 27 November 2020 at the Steve Biko Academic Hospital (Tshwane District Hospital).


Over 50 people visited the 3 screening stations set up at the hospital where trained nurses conducted clinical breast examinations and prostate-specific antigen (PSA) tests. Screening days form part of Phakamisa’s Awareness pillar which focuses
on building understanding within our communities, hosting awareness and screening events, providing informative pamphlets and illustrative diagrams about breast and prostate cancer.